Cardiol Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRDL and other ETFs, options, and stocks.

About CRDL

Cardiol Therapeutics, Inc. is a clinical-stage life sciences company focused on the research and clinical of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases.

CEO

David G. Elsley

CEODavid G. Elsley

Employees

Employees22

Headquarters

Oakville, Ontario

HeadquartersOakville, Ontario

Founded

2017

Founded2017

Employees

Employees22

CRDL Key Statistics

Market cap

119.43M

Market cap119.43M

Price-Earnings ratio

-4.20

Price-Earnings ratio-4.20

Dividend yield

—

Dividend yield—

Average volume

204.94K

Average volume204.94K

High today

—

High today—

Low today

—

Low today—

Open price

$1.51

Open price$1.51

Volume

0.00

Volume0.00

52 Week high

$2.63

52 Week high$2.63

52 Week low

$0.7709

52 Week low$0.7709

People also own

Based on the portfolios of people who own CRDL. This list is generated using Robinhood data, and it’s not a recommendation.